Skip to main content

2 Result(s)

within Yang-kui Gu Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study

    Hepatic arterial infusion chemotherapy (HAIC) using a combination of oxaliplatin, fluorouracil, and leucovorin (FOLFOX) has shown promise for hepatocellular carcinoma (HCC) patients classified under Barcelona ...

    Tian-Qi Zhang, Zhi-Jun Geng, Meng-Xuan Zuo… in Signal Transduction and Targeted Therapy (2023)

    Download PDF (1399 KB) View Article

  2. No Access

    Article

    Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma

    Anti-programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) therapy has shown promise in tumor immunotherapy. Our objectives were to measure pre-treatment serum-soluble PD-L1 (sPD-L1) levels and...

    Xue Han, Yang-kui Gu, Shao-long Li, Hao Chen… in Journal of Cancer Research and Clinical On… (2019)